Department of Imaging, Section of Interventional Radiology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Acta Radiol. 2021 Sep;62(9):1142-1147. doi: 10.1177/0284185120959829. Epub 2020 Sep 22.
Percutaneous cholecystostomy is performed by interventional radiologists for patients with calculous/acalculous cholecystitis who are poor candidates for cholecystectomy. Two anatomical approaches are widely utilized: transperitoneal and transhepatic.
To compare the clinical outcomes of transperitoneal and transhepatic approaches to cholecystostomy catheter placement.
From December 2007 to August 2015, 165 consecutive patients (97 men, 68 women) underwent either transperitoneal (n = 89) or transhepatic (n = 76) cholecystostomy at a single center. Indications were calculous cholecystitis (n = 21), acalculous cholecystitis (n = 35), hydrops (n = 1), gangrenous cholecystitis (n = 1), and other cholecystitis (n = 107). The most common high-risk co-morbidities were sepsis (n = 53) and cardiac (n = 11). Outcomes were compared using univariate and multivariable analysis.
Post-procedure outcomes included tube dislodgement (transperitoneal [n = 6] and transhepatic [n = 3], = 0.44), bile leak (transperitoneal [n = 5], transhepatic [n = 1], = 0.14), gallbladder hemorrhage (transperitoneal [n = 2]; transhepatic [n = 3], = 0.52), duodenal fistula (transperitoneal [n = 0], transhepatic [n = 1], = 0.27), repeat cholecystostomy (transperitoneal [n = 1], transhepatic [n = 3], = 0.27), and repeat cholecystitis requiring separate admission (transperitoneal [n = 6], transhepatic [n = 10], = 0.15). All complications were Common Terminology Criteria for Adverse Events grade <3. Twenty transperitoneal patients underwent post-procedure cholecystectomy: 13 laparoscopic, three open, and four unclear/outside records. The mean time from cholecystostomy to operation was 38 days (range 3-211 days). Twenty-three transhepatic patients underwent cholecystectomy: 14 laparoscopic, eight open, and one unclear/outside records, with the mean time from cholecystostomy being 98 days (range 0-1053 days). One transhepatic and three transperitoneal patients died during admission.
There were no significant differences in short-term complications after transperitoneal and transhepatic approaches to percutaneous cholecystostomy catheter placement.
经皮胆囊造口术由介入放射科医生为不适合胆囊切除术的结石性/非结石性胆囊炎患者进行。有两种广泛应用的解剖途径:经腹腔和经肝。
比较经腹腔和经肝途径放置胆囊造口管的临床效果。
2007 年 12 月至 2015 年 8 月,在一家单中心对 165 例连续患者(97 名男性,68 名女性)进行了经腹腔(n=89)或经肝(n=76)胆囊造口术。适应证为结石性胆囊炎(n=21)、非结石性胆囊炎(n=35)、水肿(n=1)、坏疽性胆囊炎(n=1)和其他胆囊炎(n=107)。最常见的高危合并症为脓毒症(n=53)和心脏疾病(n=11)。使用单变量和多变量分析比较结果。
术后结果包括管移位(经腹腔[n=6]和经肝[n=3],=0.44)、胆漏(经腹腔[n=5]和经肝[n=1],=0.14)、胆囊出血(经腹腔[n=2];经肝[n=3],=0.52)、十二指肠瘘(经腹腔[n=0]和经肝[n=1],=0.27)、重复胆囊造口术(经腹腔[n=1]和经肝[n=3],=0.27)和需要单独入院的重复胆囊炎(经腹腔[n=6]和经肝[n=10],=0.15)。所有并发症均为不良事件通用术语标准等级<3。20 例经腹腔患者行术后胆囊切除术:13 例腹腔镜,3 例开放,4 例记录不清/院外。胆囊造口术至手术的平均时间为 38 天(范围 3-211 天)。23 例经肝患者行胆囊切除术:14 例腹腔镜,8 例开放,1 例记录不清/院外,胆囊造口术至手术的平均时间为 98 天(范围 0-1053 天)。1 例经肝和 3 例经腹腔患者在住院期间死亡。
经腹腔和经肝途径行经皮胆囊造口术导管置入的短期并发症无显著差异。